^
    Apply
    Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (NCT05768321)
    Phase 1
    GenEros Biopharma Hangzhou Ltd
    Recruiting
    Last update posted :
    03/16/2023
    Initiation :
    11/04/2021
    Primary completion :
    02/28/2024
    Completion :
    05/30/2024
    KRAS • STK11 • KEAP1
    |
    KRAS mutation • KRAS G12C • KRAS G12
    |
    GEC-255